Drug:
Reaction: GAIT DISTURBANCE
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26931605 |
US |
1 | |
Goitre, Tunnel vision, Thyroid pain, Dizziness, Gait disturbance, Cerebrovascular accident, Drug ineffective, |
||||
LEVOTHYROXINE SODIUM, |
||||
| 102 | 26931651 |
US |
3 | 2 |
Muscle spasms, Gait disturbance, Insomnia, |
||||
DUPILUMAB, |
||||
| 103 | 26931735 |
CA |
43 | 2 |
Dyspnoea, Medication error, Gait inability, Prescribed overdose, Therapeutic product effect decreased, Facet joint syndrome, Product use in unapproved indication, Crohn^s disease, Gastrointestinal disorder, Drug tolerance, Therapeutic product effect incomplete, Therapy non-responder, Dyspepsia, Confusional state, Prescribed underdose, Condition aggravated, Drug intolerance, Drug hypersensitivity, Product use issue, Ear pain, Fibromyalgia, Gait disturbance, Bone erosion, Drug ineffective, Duodenal ulcer perforation, Treatment failure, Delirium, |
||||
MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, HYDROXYCHLOROQUINE SULFATE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, TOCILIZUMAB, TOCILIZUMAB, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ADALIMUMAB-ADAZ, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, CANDESARTAN, CANDESARTAN, CANDESARTAN, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CALCIUM CARBONATE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, SACCHAROMYCES CEREVISIAE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ERENUMAB-AOOE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, OXYCODONE, OXYCODONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, |
||||
| 104 | 26932038 |
66 | ||
Dizziness, Bradycardia, Dyspnoea exertional, Gait disturbance, Anxiety, Fatigue, |
||||
PALTUSOTINE, CYANOCOBALAMIN, LATANOPROST, TIMOLOL, BRIMONIDINE, BRIMONIDINE TARTRATE, |
||||
| 105 | 26932679 |
US |
37 | 2 |
Pain in extremity, Gait disturbance, |
||||
DUPILUMAB, |
||||
| 106 | 26932720 |
EU |
65 | 2 |
Myasthenia gravis, Poor quality sleep, Decreased appetite, Vomiting, Infection, Pain in extremity, Nausea, Hypergeusia, Fatigue, Alopecia, Diarrhoea, Headache, Drug ineffective, Gait disturbance, |
||||
ROZANOLIXIZUMAB, ROZANOLIXIZUMAB, |
||||
| 107 | 26932733 |
US |
82 | 2 |
Gait inability, Hypoaesthesia, Nodule, Oedema peripheral, Muscular weakness, Rheumatoid arthritis, Movement disorder, Drug ineffective, Gait disturbance, Peripheral swelling, Rheumatoid arthritis, |
||||
UPADACITINIB, UPADACITINIB, UPADACITINIB, UPADACITINIB, |
||||
| 108 | 26932850 |
US |
61 | 2 |
Gait disturbance, Erythema, Skin burning sensation, Speech disorder, Product dose omission issue, Hypoaesthesia, |
||||
DIROXIMEL FUMARATE, DIROXIMEL FUMARATE, |
||||
| 109 | 26932952 |
95 | ||
Malaise, Gait disturbance, Peripheral vascular disorder, Neck pain, Nervousness, |
||||
METOPROLOL TARTRATE, RALOXIFENE HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LOVASTATIN, CLOPIDOGREL, LANSOPRAZOLE, LISINOPRIL, |
||||
| 110 | 26933312 |
US |
1 | |
Hallucination, Confusional state, Gait disturbance, Oedema peripheral, Product use in unapproved indication, |
||||
PIMAVANSERIN TARTRATE, POLYETHYLENE GLYCOL 3350, VITAMIN C, |
||||
| 111 | 26933675 |
US |
53 | |
Immune effector cell-associated neurotoxicity syndrome, Alopecia, Gait disturbance, Asthenia, |
||||
AXICABTAGENE CILOLEUCEL, |
||||
| 112 | 26933762 |
EU |
87 | 2 |
Gait disturbance, Tremor, |
||||
GABAPENTIN, |
||||
| 113 | 26926958 |
EG |
24 | 1 |
Thrombosis, Limb mass, Gait disturbance, |
||||
INTERFERON BETA-1A, INTERFERON BETA-1A, |
||||
| 114 | 26927683 |
US |
2 | |
Hallucination, visual, Personality change, Behaviour disorder, Confusional state, Gait disturbance, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, FAMOTIDINE, GLIPIZIDE, TIMOLOL, CITALOPRAM, CITALOPRAM HYDROBROMIDE, LATANOPROST, LISINOPRIL, |
||||
| 115 | 26928044 |
71 | ||
Heart rate abnormal, Blood pressure inadequately controlled, Somnolence, Gait disturbance, |
||||
METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, FENOFIBRATE, CLOPIDOGREL, VALSARTAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 116 | 26928087 |
71 | ||
Muscle spasms, Gait disturbance, |
||||
METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, |
||||
| 117 | 26928544 |
US |
70 | 2 |
Coma, Spinal operation, Bladder disorder, Gait disturbance, Amnesia, Incorrect dose administered by device, Device use error, Product communication issue, |
||||
ETANERCEPT, ETANERCEPT, |
||||
| 118 | 26928569 |
US |
14 | 2 |
Pneumonia, Gait disturbance, Delusion, Product dose omission issue, Device malfunction, Device issue, Product temperature excursion issue, Product availability issue, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 119 | 26929206 |
US |
81 | 2 |
Knee arthroplasty, Multiple fractures, Arthralgia, Muscle spasms, Crying, Paraesthesia, Fall, Gait disturbance, Burning sensation, Drug ineffective, Arthralgia, Adverse drug reaction, Pain in extremity, Arthralgia, Ill-defined disorder, Drug effect less than expected, Apathy, Pain, |
||||
ROMOSOZUMAB-AQQG, DENOSUMAB, CALCIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, CETIRIZINE HYDROCHLORIDE, |
||||
| 120 | 26929674 |
US |
||
Gait disturbance, Balance disorder, Dizziness, Feeling drunk, |
||||
ACORAMIDIS HYDROCHLORIDE, |
||||
| 121 | 26930118 |
GB |
60 | 2 |
Arthralgia, Dizziness postural, Gait disturbance, Pain, Back pain, Poor quality sleep, Disturbance in attention, Dyspnoea, Headache, Fatigue, |
||||
CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, |
||||
| 122 | 26930123 |
EU |
82 | 2 |
Eructation, Pulmonary hypertension, Hiatus hernia, Inflammatory marker increased, Hepatic cyst, Gait disturbance, Coronary artery disease, Decreased appetite, Urinary tract infection, Acute kidney injury, Aplastic anaemia, Urinary retention, Wound dehiscence, Arterial haemorrhage, Diverticulum intestinal, Pancreatic steatosis, Myocardial infarction, Haemarthrosis, Tricuspid valve incompetence, Myelodysplastic syndrome, Impaired healing, General physical health deterioration, Cardiogenic shock, Faecaloma, Left ventricular dysfunction, Abdominal discomfort, Arthralgia, Femoral hernia incarcerated, Fall, Mitral valve incompetence, Dyspnoea, Wound infection pseudomonas, Postoperative wound infection, Escherichia infection, Joint dislocation, Aortic valve stenosis, Cardiovascular disorder, Anaemia, Gastrointestinal haemorrhage, Lymphatic fistula, Seroma, Groin pain, |
||||
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE, PANTOPRAZOLE, PANTOPRAZOLE, EDOXABAN TOSYLATE, EDOXABAN TOSYLATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, SIMVASTATIN, TORSEMIDE, TORSEMIDE, CLOPIDOGREL BISULFATE, AMIODARONE HYDROCHLORIDE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, VALSARTAN, VALSARTAN ORAL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FENTANYL, ESOMEPRAZOLE, ESOMEPRAZOLE, TORSEMIDE, TORSEMIDE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, FOLIC ACID, LACTULOSE, TROSPIUM CHLORIDE, TROSPIUM CHLORIDE, |
||||
| 123 | 26930437 |
US |
2 | |
Unevaluable event, Pain, Paralysis, Gait disturbance, |
||||
ADALIMUMAB, |
||||
| 124 | 26930447 |
JP |
78 | 2 |
Gait disturbance, Neuropathy peripheral, Otitis media, |
||||
ELRANATAMAB-BCMM, ELRANATAMAB-BCMM, ELRANATAMAB-BCMM, |
||||
| 125 | 26930889 |
EU |
15 | 2 |
Suicide attempt, Intentional overdose, Vertigo, Gait disturbance, |
||||
SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, |
||||
| 126 | 26930896 |
US |
2 | |
Gait disturbance, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
| 127 | 26937234 |
|||
Vomiting, Weight increased, Myalgia, Arthralgia, Musculoskeletal stiffness, Gait disturbance, Neuropathy peripheral, Limb crushing injury, Sleep disorder, |
||||
| 128 | 26937971 |
68 | 2 | |
Arthralgia, Gait disturbance, Pain, |
||||
INCLISIRAN, EZETIMIBE, INCLISIRAN, |
||||
| 129 | 26921374 |
US |
80 | 2 |
Dementia, Memory impairment, Weight decreased, Decreased appetite, Mobility decreased, Condition aggravated, Gait disturbance, |
||||
PIMAVANSERIN TARTRATE, DULOXETINE HYDROCHLORIDE, DULOXETINE, GABAPENTIN, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, MAGNESIUM OXIDE, CARBIDOPA AND LEVODOPA, SPIRONOLACTONE, VALSARTAN, VALSARTAN ORAL, DONEPEZIL HYDROCHLORIDE, AMANTADINE, DULOXETINE HYDROCHLORIDE, |
||||
| 130 | 26921590 |
US |
||
Physical deconditioning, Muscular weakness, Eye disorder, Gait disturbance, Hypoacusis, |
||||
OCRELIZUMAB, |
||||
| 131 | 26921795 |
CA |
43 | 2 |
Epilepsy, Arthralgia, Abdominal pain upper, Dry mouth, Dyspepsia, Anxiety, Incorrect route of product administration, Gait disturbance, Anti-cyclic citrullinated peptide antibody positive, Folliculitis, Fatigue, Adverse event, Medication error, Live birth, Off label use, Adjustment disorder with depressed mood, Product use issue, Exposure during pregnancy, Exostosis, Fibromyalgia, Amnesia, Ear pain, Drug tolerance, Facet joint syndrome, Adverse drug reaction, Dyspnoea, |
||||
AZELAIC ACID, 12%AZELAIC ACID, 14%AZELAIC ACID, RANITIDINE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, CYCLOBENZAPRINE, HYDROMORPHONE HYDROCHLORIDE, CELECOXIB, MIRABEGRON, MIRABEGRON, CERTOLIZUMAB PEGOL, ALENDRONATE SODIUM, ALENDRONATE SODIUM, QUETIAPINE FUMARATE, QUETIAPINE, CANDESARTAN, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ALENDRONATE SODIUM, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, MEPOLIZUMAB, ERENUMAB-AOOE, PHENYLEPHRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, LAMOTRIGINE, LAMOTRIGINE, ABATACEPT, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, APREMILAST, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, PREGABALIN, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, SECUKINUMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, GOLD, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, CAFFEINE CITRATE, CALCIUM GLUCONATE, |
||||
| 132 | 26921958 |
US |
76 | 2 |
Device difficult to use, Drug dose omission by device, Gait disturbance, Incorrect disposal of product, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 133 | 26922116 |
BR |
2 | |
Suicide attempt, Suicidal ideation, Asthenia, Pain, Feeling abnormal, Headache, Wound, Asphyxia, Neoplasm, Tumour pain, Apathy, Swelling, Renal impairment, Cardiac arrest, Eye disorder, Cardiac arrest, Coronavirus infection, Neoplasm malignant, Cardiomegaly, Pancreatic enlargement, Abnormal organ growth, Metastatic carcinoid tumour, Throat cancer, Metastasis, Metastasis, Disease recurrence, Metastases to bone, Diabetes mellitus, Bone pain, Bone marrow infiltration, Malaise, Cataract, Acromegaly, Lung disorder, Syncope, Pruritus, Pneumonia, Arrhythmia, Bone disorder, Visual impairment, Nervousness, Agitation, Feeding disorder, Mass, Panic reaction, Fear, Stress, Skin hypertrophy, Skin discolouration, Balance disorder, Hepatomegaly, Crying, Mood altered, Endocrine disorder, Deformity, Dyskinesia, Fall, Foot deformity, Dysphonia, Needle issue, Productive cough, Coating in mouth, Coating in mouth, Hormone level abnormal, Pancreatic disorder, Tongue disorder, Cardiac disorder, Gallbladder disorder, Liver disorder, Bacteroides test positive, Head injury, Malaise, Retching, Laziness, Skin discolouration, Malaise, Gait disturbance, Haemangioma of bone, Yellow skin, Cardiac valve disease, Gait disturbance, Decreased immune responsiveness, Sluggishness, General physical condition abnormal, Cyanosis, Neuralgia, Oropharyngeal pain, Dyspnoea, Pyrexia, Platelet count decreased, Vomiting, Muscular weakness, Decreased appetite, Headache, Asthenia, Headache, Insomnia, Influenza like illness, Anxiety, Dyspnoea, Fatigue, Back pain, Injection site pain, Therapeutic product effect delayed, Incorrect dose administered, Product quality issue, Product storage error, Inappropriate schedule of product administration, Product physical issue, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, SERTRALINE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 134 | 26922188 |
CO |
72 | 2 |
Eye operation, Malaise, Blindness, Blood cholesterol increased, Musculoskeletal pain, Back pain, Arthralgia, Gait disturbance, Eye inflammation, Eye haemorrhage, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 135 | 26922679 |
CA |
56 | |
Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Condition aggravated, Delirium, Diabetes mellitus, Diarrhoea, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Drug intolerance, Fatigue, Fibromyalgia, Gait disturbance, Glossodynia, Grip strength decreased, Hand deformity, Liver injury, Mobility decreased, Muscular weakness, Nausea, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Arthropathy, Psoriatic arthropathy, Rheumatoid arthritis, Seronegative arthritis, Swelling, Synovitis, Type 2 diabetes mellitus, Weight decreased, Wheezing, Oedema, Hypersensitivity, Rash, Systemic lupus erythematosus, Urticaria, Visual impairment, Vomiting, Weight increased, Upper respiratory tract infection, Wound infection, Treatment failure, Therapeutic product effect decreased, Maternal exposure during pregnancy, Underdose, Product use issue, Prescribed underdose, Product use in unapproved indication, Prescribed overdose, Off label use, Contraindicated product administered, Drug ineffective, Drug tolerance decreased, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, RITUXIMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, LEFLUNOMIDE, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, LEFLUNOMIDE, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, CALCIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, SULFASALAZINE, |
||||
| 136 | 26922720 |
US |
77 | 2 |
Gait disturbance, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 137 | 26922777 |
EU |
66 | 1 |
Lower limb fracture, Hallucination, visual, Arthralgia, Gait disturbance, |
||||
MOXIFLOXACIN HYDROCHLORIDE, |
||||
| 138 | 26923181 |
BR |
2 | |
Drug intolerance, Immunodeficiency, Epistaxis, Loss of consciousness, Haemangioma rupture, Liver injury, Spinal cord disorder, Spinal cord injury, Metastases to spine, Metastases to bone, Metastasis, Metastases to bone, Metastases to liver, Immunodeficiency, Face injury, Skin exfoliation, Dry throat, Alopecia, Erythema, Dry skin, Vulvovaginal dryness, Vulvovaginal discomfort, Vulvovaginal burning sensation, Nasal dryness, Skin disorder, Pruritus, Neoplasm, Gait disturbance, Tumour marker increased, Reflux gastritis, Discouragement, Visual impairment, Greater trochanteric pain syndrome, Feeding disorder, Haemangioma, Disease progression, Weight decreased, Illness, Aphthous ulcer, Oral herpes, Swelling of eyelid, Sinusitis, Rhinitis, Rhinitis allergic, Eyelid sensory disorder, Vein disorder, Frostbite, Ocular hyperaemia, Haemorrhoids, Hair texture abnormal, Trichorrhexis, Eyelid ptosis, Rectocele, Gastrointestinal disorder, Hiatus hernia, Nasal pruritus, Dry eye, Head discomfort, PIK3CA-activated mutation, Swelling, Abdominal discomfort, Head injury, Nasal injury, Skin lesion, Wound, Injury, Oestrogen deficiency, Drug ineffective, Panic disorder, Nasal discomfort, Haematoma, Asthenopia, Hypermetropia, Astigmatism, Petechiae, Dyspnoea, Skeletal injury, Phlebitis, Oral pain, Nasal disorder, Eye swelling, Anosmia, Movement disorder, Pain, Vulvovaginal exfoliation, Chills, Paraesthesia, White blood cell count decreased, Neutrophil count decreased, Pyrexia, Fatigue, Constipation, Dry mouth, Application site bruise, Application site pain, Ear disorder, Urinary tract infection, Skin atrophy, Lip dry, Pain, Pain in extremity, Bone pain, Dysstasia, Application site swelling, Arthralgia, Insomnia, Malaise, Product availability issue, |
||||
FULVESTRANT, ANASTROZOLE, ANASTROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, FULVESTRANT, FULVESTRANT, FULVESTRANT, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, ERGOCALCIFEROL, ACONITUM NAPELLUS, BRYONIA ALBA, EUPATORIUM PERFOLIATUM, FERRUM PHOSPHORICUM, GELSEMIUM SEMPERVIRENS, KALI BICHROMICUM, KALI LODATUM, ZINCUM GLUCONICUM., DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL, ACONITUM NAPELLUS, ALLIUM CEPA, GELSEMIUM SEMP., ZINCUM GLUCONICUM, BAPTISIA TINCTORIA, ECHINACEA ANGUSTIFOLIA, EUPATORIUM PERFOLIATUM, LOMATIUM DISSECTUM, PUERARIA LOBATA, TRIFOLIUM PRATENSE, PHYTOLACCA DECANDRA, ALLIUM CEPA, ARSENICUM IODATUM, BARYTA CARBONICA, BROMIUM, CALCAREA CARBONICA, KALI MURIATICUM, LACHESIS MUTUS, MERCURIUS SOLUBILIS, SILICEA, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL, |
||||
| 139 | 26923368 |
US |
||
Gait disturbance, |
||||
TIRZEPATIDE, |
||||
| 140 | 26923399 |
US |
1 | |
Gait disturbance, Pain, Off label use, |
||||
BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, |
||||
| 141 | 26923655 |
US |
1 | |
Asthenia, Dizziness, Gait disturbance, Mobility decreased, Pain, Peripheral swelling, Headache, |
||||
TESTOSTERONE CYPIONATE, |
||||
| 142 | 26923976 |
EU |
66 | 1 |
Lower limb fracture, Hallucination, visual, Arthralgia, Gait disturbance, |
||||
MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, |
||||
| 143 | 26924038 |
EU |
2 | |
Subarachnoid haemorrhage, Ruptured cerebral aneurysm, Headache, Musculoskeletal stiffness, Intracranial aneurysm, Expanded disability status scale score increased, Spinal cord disorder, Central nervous system lesion, Vertebral lesion, Treatment failure, Dysarthria, Gait disturbance, Motor dysfunction, Hypertension, Dyslipidaemia, |
||||
FINGOLIMOD HCL, FINGOLIMOD, FINGOLIMOD HYDROCHLORIDE, |
||||
| 144 | 26924260 |
US |
2 | |
Anaphylactic reaction, Mouth swelling, Dyspnoea, Gait disturbance, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 145 | 26924894 |
US |
51 | 2 |
Pain, Gait disturbance, Musculoskeletal disorder, |
||||
DIROXIMEL FUMARATE, |
||||
| 146 | 26924899 |
EU |
86 | 1 |
Hallucination, Pneumonia, Speech disorder, Gait disturbance, |
||||
ROTIGOTINE, |
||||
| 147 | 26925711 |
55 | 2 | |
Dizziness, Gait disturbance, Headache, Mental status changes, Respiratory failure, Disease progression, Cerebral ventricle dilatation, |
||||
ETOMIDATE, ETOMIDATE INJECTION, FENTANYL, LEVETIRACETAM, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, PROPOFOL, TOCILIZUMAB, TEMAZEPAM, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM, PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM, |
||||
| 148 | 26930300 |
81 | 1 | |
Anaemia, Oedema, Gait disturbance, Exercise tolerance decreased, Vomiting, Muscular weakness, |
||||
ADALIMUMAB, |
||||
| 149 | 26931044 |
2 | ||
Bradycardia, Tinnitus, Headache, Somnolence, Asthenia, Nausea, Decreased appetite, Urine output decreased, Gait disturbance, Mood altered, Pain in extremity, Musculoskeletal pain, |
||||
AMLODIPINE BESYLATE, HYDROCHLOROTHIAZIDE, LATANOPROST, ERGOCALCIFEROL, |
||||
| 150 | 26915104 |
AU |
64 | 1 |
Off label use, Gait disturbance, Deep vein thrombosis, Asthenia, Skin abrasion, Skin exfoliation, Type 2 diabetes mellitus, Multiple sclerosis, |
||||
OCRELIZUMAB, |
||||
| 151 | 26915459 |
US |
70 | 1 |
Gait disturbance, |
||||
PIMAVANSERIN TARTRATE, POLYETHYLENE GLYCOL 3350, DROXIDOPA, PANTOPRAZOLE SODIUM, ONABOTULINUMTOXINA, FLECAINIDE ACETATE TABLET, FLECAINIDE ACETATE, NICOTINE, NICOTINE TRANSDERMAL SYSTEM, FLUDROCORTISONE ACETATE, ESCITALOPRAM, IRON, CLONAZEPAM, ISTRADEFYLLINE, BUSPIRONE HYDROCHLORIDE, ERGOCALCIFEROL, MELATONIN, LORATADINE, LORATADINE ORAL, WARFARIN SODIUM, WARFARIN, BUMETANIDE, OPICAPONE, CARBIDOPA AND LEVODOPA, RIVASTIGMINE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, MONTELUKAST SODIUM, |
||||
| 152 | 26915592 |
US |
2 | |
Hip fracture, Pain in extremity, Fall, Gait disturbance, Mobility decreased, Muscular weakness, Arthralgia, |
||||
DUPILUMAB, |
||||
| 153 | 26915719 |
BR |
2 | |
Vulvovaginal injury, Spinal fracture, Vein rupture, Metastases to bone, Metastases to spine, Metastases to liver, Metastasis, Haemorrhage, Hydronephrosis, Urinary retention, Seizure, Breast cancer, Malignant neoplasm progression, Nail cuticle fissure, Epistaxis, Dry skin, Dry mouth, Constipation, Vulvovaginal dryness, Drug ineffective, Petechiae, Skin tightness, Visual impairment, Skin fissures, Skin atrophy, Dry throat, Nasal mucosal disorder, Rhinalgia, Secretion discharge, Insomnia, Throat irritation, Hair texture abnormal, Skin exfoliation, Breast disorder, Tumour marker increased, Calcification metastatic, Weight increased, Flatulence, Reflux gastritis, Hiatus hernia, Gastritis, Muscle spasms, Vitamin B12 deficiency, Feeding disorder, Balance disorder, Head injury, Fall, Dermal absorption impaired, Thermal burn, Nasal congestion, Eye swelling, Phlebitis, Rhinitis allergic, Allergic sinusitis, Decreased immune responsiveness, Gastric polyps, Skeletal injury, Pelvic bone injury, Epistaxis, Oropharyngeal discomfort, Hypersensitivity, Discomfort, Quality of life decreased, Rectocele, Bone lesion, Product distribution issue, Thinking abnormal, Feeling abnormal, Carbohydrate antigen 15-3 increased, PIK3CA-activated mutation, Quality of life decreased, Feeding disorder, Sensory disturbance, Skin discolouration, COVID-19, Bone pain, Condition aggravated, Anosmia, Malaise, Gene mutation, Urinary tract infection, Oral pain, Muscle injury, Hepatic mass, Dysbiosis, Oral disorder, Speech disorder, Chills, Lip swelling, Gait disturbance, Gastrointestinal disorder, Pain, Depressed mood, Myalgia, Atrophic vulvovaginitis, Nasal disorder, Head injury, Malaise, Tumour marker abnormal, Central nervous system lesion, Hepatic lesion, Cervix disorder, Uterine leiomyoma, Bacteriuria, Swelling face, Pruritus, Erythema, White blood cell count decreased, Nausea, Peripheral swelling, Vomiting, Diarrhoea, Nasopharyngitis, Dizziness, Abdominal pain upper, Cough, Retching, Fatigue, Sinusitis, Infection, Rhinitis, Abdominal pain, Dyspnoea, Abdominal discomfort, Drug resistance, Pain, Pain in extremity, Head discomfort, Decreased appetite, Vision blurred, Illness, Weight decreased, Arthralgia, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, PANTOPRAZOLE, FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ALPELISIB, LORATADINE, LORATADINE ORAL, LORATADINE, LORATADINE ORAL, LORATADINE, LORATADINE ORAL, EXEMESTANE, CLONAZEPAM, CAPECITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, ERGOCALCIFEROL, |
||||
| 154 | 26915758 |
US |
66 | 2 |
Tachycardia, Myasthenic syndrome, Condition aggravated, Tinnitus, Electric shock sensation, Gait disturbance, Vision blurred, Eyelid ptosis, Abdominal pain upper, Paraesthesia oral, Back pain, Paraesthesia, Muscular weakness, Muscular weakness, Dizziness, |
||||
AMIFAMPRIDINE PHOSPHATE, AMIFAMPRIDINE PHOSPHATE, AMIFAMPRIDINE PHOSPHATE, AMIFAMPRIDINE PHOSPHATE, AMIFAMPRIDINE PHOSPHATE, AMIFAMPRIDINE PHOSPHATE, PYRIDOSTIGMINE BROMIDE, HUMAN IMMUNOGLOBULIN G, |
||||
| 155 | 26915769 |
US |
80 | |
Gait disturbance, |
||||
ORAL SEMAGLUTIDE, |
||||
| 156 | 26915816 |
EU |
72 | 1 |
Vertigo, Headache, Gait disturbance, Confusional state, |
||||
PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, CEFOTAXIME, CEFOTAXIME INJECTION, AMOXICILLIN, GENTAMICIN, GENTAMICIN SULFATE, ACYCLOVIR, METHYLPREDNISOLONE, |
||||
| 157 | 26915873 |
US |
2 | |
Gait disturbance, Scratch, Haemorrhage subcutaneous, Dementia, Gout, Pruritus, |
||||
DUPILUMAB, |
||||
| 158 | 26916019 |
US |
1 | |
Heart rate increased, Somnolence, Gait disturbance, Loss of personal independence in daily activities, Tremor, Anxiety, Agitation, Insomnia, Product complaint, |
||||
ZOLPIDEM TARTRATE, |
||||
| 159 | 26916073 |
US |
||
Asthenia, Gait disturbance, |
||||
UPADACITINIB, |
||||
| 160 | 26916160 |
CA |
43 | 2 |
Fibromyalgia, Folliculitis, Gait disturbance, Fatigue, Arthropathy, Autoimmune disorder, Breast cancer stage II, Abdominal discomfort, Hypocholesterolaemia, Retinitis, Visual impairment, Product use issue, Incorrect route of product administration, Medication error, Off label use, |
||||
DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, OXYCODONE HYDROCHLORIDE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREGABALIN, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, OXYCODONE, OXYCODONE, OXYCODONE, CELECOXIB, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 161 | 26916629 |
US |
1 | |
Pyrexia, Neuropathy peripheral, Off label use, Haematocrit decreased, Asthenia, Gait disturbance, Haemoglobin decreased, Fatigue, |
||||
OLAPARIB, CISPLATIN, |
||||
| 162 | 26916726 |
EU |
||
Pneumonia bacterial, Atrial fibrillation, Tinnitus, Bowel movement irregularity, Arthralgia, Brain fog, Pyrexia, Gait disturbance, Malaise, Asthenia, |
||||
ALIROCUMAB, |
||||
| 163 | 26916886 |
AR |
2 | |
Device issue, Arthralgia, Gait disturbance, Product dose omission issue, |
||||
GOLIMUMAB, |
||||
| 164 | 26917624 |
35 | 2 | |
Burn of internal organs, Chemical burn of genitalia, Gait disturbance, Vulvovaginal pain, |
||||
MICONAZOLE NITRATE, INSULIN ASPART, |
||||
| 165 | 26917806 |
US |
1 | |
Gait disturbance, Tremor, |
||||
ILOPERIDONE, |
||||
| 166 | 26917909 |
US |
2 | |
Pain, Urinary tract infection, Granuloma, Multi-organ disorder, Haemolysis, Vaginal odour, Limb discomfort, Infection, Gait disturbance, |
||||
RAVULIZUMAB, |
||||
| 167 | 26918002 |
EU |
66 | 1 |
Hallucination, visual, Lower limb fracture, Arthralgia, Gait disturbance, |
||||
MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, |
||||
| 168 | 26918173 |
EU |
34 | 2 |
Neuropathy peripheral, Epistaxis, Gait disturbance, Product use issue, Maternal exposure during pregnancy, Peripheral nerve injury, Paraesthesia, Live birth, Epidural analgesia, Epidural haemorrhage, Spinal epidural haemorrhage, Foetal heart rate abnormal, Nervous system disorder, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, KETOPROFEN, KETOPROFEN, KETOPROFEN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ROPIVACAINE HYDROCHLORIDE, ROPIVACAINE HYDROCHLORIDE, ROPIVACAINE HYDROCHLORIDE, ROPIVACAINE HYDROCHLORIDE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, EPINEPHRINE, ADRENALINUM, EPINEPHRINE, ADRENALINUM, EPINEPHRINE, ADRENALINUM, ENOXAPARIN SODIUM, |
||||
| 169 | 26918959 |
BR |
83 | 2 |
Corneal opacity, Retinal deposits, Gait disturbance, Dyspnoea, Hypertension, Fatigue, Asthenia, Dysarthria, Memory impairment, Somnolence, Apathy, Tremor, Confusional state, Heart rate irregular, Vision blurred, Dry eye, Toxicity to various agents, Ocular hyperaemia, |
||||
BELANTAMAB MAFODOTIN, POMALIDOMIDE, POMALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 170 | 26919436 |
US |
2 | |
Weight decreased, Dehydration, Thyroid disorder, Balance disorder, Gait disturbance, Blood pressure decreased, Oxygen saturation decreased, Orthopnoea, Dysstasia, Infection, |
||||
RAVULIZUMAB, |
||||
| 171 | 26919890 |
US |
83 | 2 |
Eyelid margin crusting, Fall, Gait disturbance, |
||||
ACOLTREMON, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CYCLOSPORINE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, LIRAGLUTIDE, ERGOCALCIFEROL, |
||||
| 172 | 26919913 |
24 | 2 | |
Tendon pain, Muscular weakness, Muscular weakness, Paraesthesia, Hypoaesthesia, Depression, Anxiety, Gait disturbance, Exercise tolerance decreased, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, MAGNESIUM, VITAMIN E, TRETINOIN, |
||||
| 173 | 26920662 |
US |
72 | 1 |
Peripheral swelling, Metastatic carcinoma of the bladder, Bladder disorder, Swelling, Gait disturbance, Drug ineffective, |
||||
NOGAPENDEKIN ALFA INBAKICEPT-PMLN, NOGAPENDEKIN ALFA INBAKICEPT-PMLN, |
||||
| 174 | 26921248 |
EU |
41 | 2 |
Initial insomnia, Arrhythmia, Pruritus, Partial seizures, Erythema, Cystitis, Cytokine storm, Multiple sclerosis, Cardiac disorder, Headache, Swelling of nose, Hypoaesthesia, Pain of skin, Tachycardia, Oral candidiasis, Fatigue, Influenza like illness, B-lymphocyte count decreased, Inflammatory marker increased, Weight decreased, Muscle spasticity, Electrocardiogram abnormal, Oropharyngeal pain, Fall, Muscular weakness, Hyperacusis, Gait disturbance, Cognitive disorder, Middle insomnia, Skin burning sensation, Urinary tract infection, Pain in extremity, Off label use, Suspected off label use, Suspected off label use, |
||||
RITUXIMAB, RITUXIMAB, OCRELIZUMAB, OCRELIZUMAB, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, BUDESONIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, TIZANIDINE HYDROCHLORIDE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, FOLIC ACID, DRONABINOL, LEVETIRACETAM, |
||||
| 175 | 26909722 |
GB |
50 | 2 |
Suicide attempt, Electric shock, Skin burning sensation, Sensory disturbance, Cellulitis, Gait disturbance, Blood folate decreased, Vitamin B12 deficiency, Neuropathy peripheral, Dystonia, Hypoaesthesia, Paraesthesia, Psychotic disorder, Aggression, Abnormal behaviour, Axonal neuropathy, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, CARBIDOPA AND LEVODOPA, AMANTADINE, |
||||
| 176 | 26909838 |
CL |
51 | 2 |
Osteonecrosis, Metastasis, Neutrophil count decreased, Breast cancer, Malignant neoplasm progression, Rectal cancer, Second primary malignancy, Metastases to bone, Bone pain, Pain, Back pain, Illness, Sinus bradycardia, Full blood count abnormal, Mean cell volume increased, Mean cell haemoglobin increased, Red cell distribution width increased, Anisocytosis, Macrocytosis, Elliptocytosis, Confusional state, Pain in extremity, Movement disorder, Polychromic red blood cells present, Neutrophil toxic granulation present, Red blood cell poikilocytes present, Lymphocyte percentage abnormal, Red blood cell count increased, Blood alkaline phosphatase decreased, Vision blurred, Red blood cell count decreased, White blood cell count decreased, Blood creatinine abnormal, Blood urea abnormal, Aspartate aminotransferase increased, Platelet count decreased, Platelet count decreased, Gait disturbance, Visual impairment, Eating disorder, Overweight, Insomnia, Anxiety, Depressed mood, Cytogenetic analysis abnormal, Platelet count increased, Inappropriate schedule of product administration, |
||||
FULVESTRANT, LETROZOLE, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, VISCUM ALBUM FRUITING TOP, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 177 | 26910130 |
CA |
2 | |
Cerebrovascular accident, Fall, Cerebrovascular accident, Pneumonia, Fall, Hypovolaemia, Peripheral swelling, Malaise, Diarrhoea, Abdominal discomfort, Fatigue, Arthropod bite, Joint swelling, Erythema, Nausea, Hypertension, Wrist fracture, Rib fracture, Head injury, Suicide attempt, Bronchitis, Productive cough, Unresponsive to stimuli, Malignant neoplasm progression, Suicidal ideation, Vasculitis, Depression, Depressed mood, Nervousness, Nervousness, Psychiatric symptom, Blood pressure increased, Depression, Tremor, Feeling jittery, Pain in extremity, Wound, Cough, Muscular weakness, Pollakiuria, Nasopharyngitis, Gait disturbance, Hypoacusis, Nervousness, Screaming, Contusion, Emotional distress, Anger, Crying, Mental disorder, Anxiety, Headache, Rash, Feeling abnormal, Inappropriate schedule of product administration, |
||||
AMLODIPINE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, GABAPENTIN, OLANZAPINE, PRUCALOPRIDE SUCCINATE, PREDNISONE, ERGOCALCIFEROL, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, CALCIUM CARBONATE, ANTACID, PANTOPRAZOLE, |
||||
| 178 | 26910237 |
BR |
2 | |
Suicide attempt, Suicidal ideation, Asthenia, Pain, Feeling abnormal, Headache, Wound, Pruritus, Asphyxia, Neoplasm, Tumour pain, Apathy, Syncope, Swelling, Renal impairment, Cardiac arrest, Eye disorder, Cardiac arrest, Coronavirus infection, Pneumonia, Neoplasm malignant, Cardiomegaly, Neoplasm malignant, Pancreatic enlargement, Abnormal organ growth, Metastatic carcinoid tumour, Throat cancer, Metastasis, Metastasis, Disease recurrence, Metastases to bone, Diabetes mellitus, Arrhythmia, Acromegaly, Bone pain, Visual impairment, Bone marrow infiltration, Nervousness, Malaise, Cataract, Mass, Lung disorder, Bone disorder, Back pain, Agitation, Insomnia, Panic reaction, Feeding disorder, Fear, Fatigue, Stress, Skin hypertrophy, Skin discolouration, Balance disorder, General physical condition abnormal, Hepatomegaly, Crying, Mood altered, Endocrine disorder, Deformity, Dyskinesia, Fall, Foot deformity, Dysphonia, Needle issue, Productive cough, Dyspnoea, Influenza like illness, Headache, Oropharyngeal pain, Incorrect dose administered, Product quality issue, Product storage error, Product physical issue, Inappropriate schedule of product administration, Muscular weakness, Myalgia, Coating in mouth, Hormone level abnormal, Therapeutic product effect delayed, Dyspnoea, Cardiac disorder, Tongue disorder, Liver disorder, Pancreatic disorder, Gallbladder disorder, Headache, Vomiting, Injection site pain, Decreased appetite, Bacteroides test positive, Head injury, Malaise, Retching, Cyanosis, Cardiac valve disease, Asthenia, Sluggishness, Platelet count decreased, Decreased immune responsiveness, Haemangioma of bone, Neuralgia, Anxiety, Gait disturbance, Malaise, Pyrexia, Yellow skin, Skin discolouration, Gait disturbance, Laziness, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, SERTRALINE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 179 | 26910302 |
CA |
43 | 2 |
Fibromyalgia, Folliculitis, Gait disturbance, Incorrect route of product administration, Product use issue, Fatigue, Arthropathy, Autoimmune disorder, Breast cancer stage II, Abdominal discomfort, Hypocholesterolaemia, Retinitis, Visual impairment, Medication error, Off label use, |
||||
ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, OXYCODONE HYDROCHLORIDE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREGABALIN, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, OXYCODONE, OXYCODONE, OXYCODONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, |
||||
| 180 | 26910414 |
CO |
36 | 2 |
Multiple sclerosis relapse, Hypoaesthesia, Gait disturbance, Gait inability, Bone pain, Gastrointestinal infection, Dizziness, Syncope, Tremor, Pyrexia, Asthenia, Muscular weakness, Fatigue, Pain, Weight decreased, Influenza, Diarrhoea, Pyrexia, Chills, Pain, |
||||
OFATUMUMAB, OFATUMUMAB, OFATUMUMAB, OFATUMUMAB, |
||||
| 181 | 26910509 |
AU |
48 | 2 |
Migraine, Balance disorder, Cardiac disorder, Dizziness, Gait disturbance, Hypoaesthesia, Myoclonus, Pain in extremity, Paraesthesia, Tremor, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 182 | 26910674 |
67 | 1 | |
Toxic encephalopathy, Altered state of consciousness, Speech disorder, Somnolence, Hypoglycaemia, Metabolic acidosis, Lactic acidosis, Off label use, Gait disturbance, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, INSULIN DEGLUDEC, |
||||
| 183 | 26910837 |
US |
84 | 1 |
Pneumonia, Cough, Pain, Gait disturbance, Spinal cord haemorrhage, International normalised ratio increased, Fall, Rib fracture, |
||||
DUPILUMAB, |
||||
| 184 | 26912088 |
AU |
||
Motor neurone disease, Gait disturbance, Eye disorder, Movement disorder, |
||||
INCLISIRAN, |
||||
| 185 | 26912362 |
CA |
88 | 2 |
Nasal congestion, Sputum retention, Asthenia, Pyrexia, Sputum discoloured, C-reactive protein increased, Dizziness, Hypotension, Gait disturbance, Chills, |
||||
RITUXIMAB-PVVR, RITUXIMAB-PVVR, RITUXIMAB-PVVR, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 186 | 26912442 |
US |
80 | 2 |
Fall, Upper limb fracture, Head injury, Blood disorder, Haematoma, Gait disturbance, Pain, Gait disturbance, Pneumonia, Finger deformity, Ill-defined disorder, Confusional state, Off label use, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ABATACEPT, AMLODIPINE BESYLATE, ANASTROZOLE, ATORVASTATIN CALCIUM, CLONAZEPAM, DICLOFENAC SODIUM, ESOMEPRAZOLE MAGNESIUM, FUROSEMIDE, GABAPENTIN, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LEVOTHYROXINE SODIUM, NALOXEGOL OXALATE, NALOXONE HYDROCHLORIDE NASAL, NALOXONE HYDROCHLORIDE, SUMATRIPTAN, TIZANIDINE HYDROCHLORIDE, ZOLPIDEM TARTRATE, |
||||
| 187 | 26912686 |
EU |
47 | 1 |
Spinal fracture, Gait disturbance, Impaired gastric emptying, Ileus paralytic, Seizure, Multiple acyl-coenzyme A dehydrogenase deficiency, Myalgia, Muscle spasms, Muscular weakness, Muscle twitching, Nausea, Vomiting, Product label issue, |
||||
SERTRALINE HYDROCHLORIDE, |
||||
| 188 | 26912789 |
CN |
70 | 2 |
Hypoaesthesia, Gait disturbance, Suspected off label use, |
||||
LINEZOLID, LINEZOLID, |
||||
| 189 | 26912790 |
US |
39 | 2 |
Cerebrovascular accident, Craniocerebral injury, Meningioma benign, Substance abuse, Facial paralysis, Dementia, Cognitive disorder, Aphasia, Gait disturbance, Dysarthria, Gastrooesophageal reflux disease, |
||||
MEDROXYPROGESTERONE ACETATE, MEDROXYPROGESTERONE ACETATE, MEDROXYPROGESTERONE ACETATE, MEDROXYPROGESTERONE ACETATE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE, |
||||
| 190 | 26912919 |
CA |
43 | 2 |
Pulmonary fibrosis, Alopecia, Product use issue, Psoriatic arthropathy, Rheumatoid arthritis, Drug tolerance decreased, Pain, Vomiting, Rheumatic fever, Joint swelling, Musculoskeletal stiffness, Infusion related reaction, Nausea, Therapeutic product effect decreased, Gastrointestinal disorder, Synovitis, Maternal exposure during pregnancy, X-ray abnormal, Rheumatoid factor positive, Product use in unapproved indication, Gait disturbance, Mobility decreased, General physical health deterioration, Pemphigus, Anti-cyclic citrullinated peptide antibody positive, Abdominal discomfort, Pneumonia, Dyspepsia, Arthropathy, Liver injury, Type 2 diabetes mellitus, Contraindicated product administered, Migraine, Live birth, Pericarditis, Drug ineffective, Fatigue, Glossodynia, Hypersensitivity, Swollen joint count increased, Systemic lupus erythematosus, Wound, Incorrect route of product administration, Duodenal ulcer perforation, Hypertension, Blood cholesterol increased, Intentional product use issue, Treatment failure, Drug intolerance, Blister, Discomfort, Rash, Off label use, Hepatic enzyme increased, Arthralgia, Headache, Hand deformity, Swelling, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, SECUKINUMAB, SECUKINUMAB, OXYCODONE HYDROCHLORIDE, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MORPHINE SULFATE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, |
||||
| 191 | 26913036 |
CA |
74 | 2 |
Haematochezia, Tremor, Renal cancer, Polyarthritis, Synovitis, Diarrhoea, Pain in extremity, Joint dislocation, Gait inability, Bursitis, Arthralgia, Gait disturbance, Peripheral swelling, Gastrointestinal ulcer, Abdominal pain upper, Constipation, Back pain, Neck pain, |
||||
SARILUMAB, SARILUMAB, METHOTREXATE, METHOTREXATE SODIUM, MORPHINE, MORPHINE, IRON, |
||||
| 192 | 26913220 |
US |
71 | 1 |
Cervical spinal stenosis, Back pain, Gait inability, Dizziness, Musculoskeletal stiffness, Freezing phenomenon, Tremor, Gait disturbance, Dysphonia, Dysphagia, Mastication disorder, Fall, |
||||
FOSCARBIDOPA/FOSLEVODOPA, AMANTADINE HYDROCHLORIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PRAMIPEXOLE DIHYDROCHLORIDE, |
||||
| 193 | 26913324 |
US |
71 | 2 |
Anaemia, Red blood cell count decreased, Fatigue, Dyspnoea exertional, Loss of personal independence in daily activities, Pain in extremity, Gait disturbance, Hypokinesia, Chronic obstructive pulmonary disease, Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 194 | 26913367 |
US |
1 | |
Muscle strain, Muscle tightness, Nocturia, Gait disturbance, Depression, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, CABOZANTINIB, METRONIDAZOLE, METRONIDAZOLE TOPICAL, PANTOPRAZOLE, CEPHALEXIN, HYDROCHLOROTHIAZIDE, |
||||
| 195 | 26913441 |
US |
78 | 2 |
Neuropathy peripheral, Balance disorder, Weight increased, Nausea, Off label use, Rash, Gastrooesophageal reflux disease, Skin disorder, Somnolence, Oedema, Gait disturbance, |
||||
POMALIDOMIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CALCIUM, DARATUMUMAB, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, |
||||
| 196 | 26913479 |
US |
2 | |
Cataract, Dizziness, Gait disturbance, Product storage issue, Wrong technique in product usage process performed in error, Product dose omission issue, |
||||
ALBUTEROL SULFATE, |
||||
| 197 | 26913495 |
CL |
62 | 2 |
Blood pressure increased, Feeling abnormal, Fall, Anxiety, Epilepsy, Ankle fracture, Migraine, Bradycardia, Hypotension, Amnesia, Blood creatinine increased, Vomiting, Nausea, Hypertension, Diarrhoea, C-reactive protein abnormal, Blood urea abnormal, Blood cholesterol abnormal, International normalised ratio abnormal, Blood potassium abnormal, Insomnia, Foot fracture, Blood alkaline phosphatase increased, Dizziness, Haematocrit decreased, Haemoglobin decreased, White blood cell count decreased, Malaise, Headache, Abnormal behaviour, Emotional distress, Skin discolouration, Depression, Ligament sprain, Myopia, Contusion, Wound, Pain, Keratitis, Thrombosis, Metastases to bone, Loss of consciousness, Asphyxia, Choking, Petit mal epilepsy, Metastases to lung, Neoplasm malignant, Neutrophil count decreased, Tinnitus, Immunodeficiency, Eye swelling, Pulmonary pain, Depressed mood, Nasal ulcer, Noninfective gingivitis, Gingival erythema, Aphthous ulcer, Weight increased, Morton^s neuralgia, Hypoglycaemia, Food intolerance, Scab, Epistaxis, Nasal injury, Gait disturbance, Ageusia, Visual impairment, Musculoskeletal chest pain, General physical health deterioration, Electric shock sensation, Full blood count decreased, Influenza, Productive cough, Cough, Pharyngitis, Haemoptysis, Pain, Fluid retention, Fat tissue increased, Dry eye, Back pain, Abdominal discomfort, Diarrhoea, Fatigue, Headache, Dysgeusia, Memory impairment, Aversion, Blood sodium increased, Eye pain, Yawning, Eyelid margin crusting, Eye disorder, Swelling, Nervousness, Anisocytosis, Poikilocytosis, Polychromasia, Macrocytosis, Elliptocytosis, Discomfort, Atrioventricular block first degree, Red cell distribution width increased, Red blood cell sedimentation rate increased, Blood glucose increased, Gastrointestinal disorder, Mean cell volume increased, Rouleaux formation, Limb deformity, Oral herpes, Ill-defined disorder, Thyroid mass, Visual impairment, Decreased immune responsiveness, Neoplasm, Arthritis, Gingival disorder, Pruritus, Hypersensitivity, Pyrexia, Red blood cell count decreased, Lymphocyte count decreased, Dry skin, Pain in extremity, Vision blurred, Herpes virus infection, Viral diarrhoea, Colitis, Chills, Agitation, Confusional state, Oesophagitis, Gastrooesophageal reflux disease, Stress, Catheter site pain, High density lipoprotein abnormal, Gait inability, Mobility decreased, Diplopia, Impaired healing, Weight decreased, Nasopharyngitis, Alopecia, Tension headache, |
||||
LETROZOLE, LETROZOLE, LETROZOLE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LANSOPRAZOLE, ERGOCALCIFEROL, CALCIUM, |
||||
| 198 | 26913531 |
EU |
66 | 1 |
Hallucination, visual, Lower limb fracture, Arthralgia, Gait disturbance, |
||||
MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, |
||||
| 199 | 26913654 |
EU |
47 | 1 |
Impaired gastric emptying, Ileus paralytic, Seizure, Spinal fracture, Multiple acyl-coenzyme A dehydrogenase deficiency, Gait disturbance, Muscular weakness, Muscle spasms, Muscle twitching, Myalgia, Nausea, Vomiting, Product label issue, |
||||
SERTRALINE, |
||||
| 200 | 26914511 |
EU |
57 | 1 |
Loss of consciousness, General physical health deterioration, Dyskinesia, Malaise, Sitting disability, Musculoskeletal discomfort, Muscle rigidity, Dizziness, Musculoskeletal stiffness, Muscle spasms, Cognitive disorder, Tremor, Hyperventilation, Gait disturbance, Medical device discomfort, Agitation, Hypotension, Fall, Limb injury, Oedema peripheral, On and off phenomenon, Weight decreased, Abnormal dreams, Hand-eye coordination impaired, Neuropathy peripheral, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
